Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?

Am J Respir Crit Care Med. 2004 May 1;169(9):1022-7. doi: 10.1164/rccm.200310-1465OC. Epub 2004 Mar 4.

Abstract

The role of exercise-induced oxidative stress in the reduced quadriceps endurance of chronic obstructive pulmonary disease (COPD) patients has never been shown. We conducted a randomized, double-blind, and crossover study in which nine severe patients performed localized dynamic quadriceps endurance tests at 40% of maximal strength after oral treatment with the antioxidant, N-acetylcysteine (NAC), and placebo. Venous blood was sampled before, immediately after exercise, and 6 hours later. Endurance time improved by 25% after NAC treatment compared with placebo (p < 0.05). Superoxide anion (oxidant) release by stimulated phagocytes decreased after treatment (p < 0.05). No change in the antioxidant system was observed. Lipid peroxidation, an index of oxidative stress, was significantly increased 6 hours after exercise in the placebo condition (p < 0.05) but not after treatment. Advanced oxidized protein products, another index of oxidative stress, were also increased 6 hours after exercise by 139 +/- 27% in the placebo condition but only by 54 +/- 19% after treatment (p < 0.05). This study shows that NAC treatment in COPD reduced basal disturbance in the prooxidant system, improved endurance time, and prevented exercise-induced oxidative stress. Oxidative stress thus seems to be implicated in the reduced quadriceps endurance of patients with COPD.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Acetylcysteine / blood
  • Acetylcysteine / pharmacokinetics
  • Acetylcysteine / pharmacology
  • Acetylcysteine / therapeutic use
  • Administration, Oral
  • Aged
  • Antioxidants / metabolism
  • Antioxidants / pharmacokinetics
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Biological Availability
  • Cross-Over Studies
  • Double-Blind Method
  • Drug Monitoring
  • Forced Expiratory Volume
  • Humans
  • Lipid Peroxidation / drug effects
  • Male
  • Middle Aged
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / physiopathology*
  • Oxidative Stress* / drug effects
  • Physical Endurance* / drug effects
  • Pulmonary Disease, Chronic Obstructive* / complications
  • Pulmonary Disease, Chronic Obstructive* / metabolism
  • Pulmonary Disease, Chronic Obstructive* / physiopathology
  • Thigh
  • Thiobarbituric Acid Reactive Substances / metabolism
  • Time Factors
  • Treatment Outcome
  • Vital Capacity

Substances

  • Antioxidants
  • Thiobarbituric Acid Reactive Substances
  • Acetylcysteine